AFT PHARMACEUTICALS

AFT
End-of-day quote. End-of-day quote  - 04/16
4.1NZD -1.68%
Business Summary
Healthcare
Pharmaceuticals & Medical Research
 Pharmaceuticals
  Pharmaceuticals
   Other Pharmaceuticals
AFT Pharmaceuticals Limited is a pharmaceutical distributor and developer of pharmaceutical intellectual property. The Company's segments include New Zealand, Australia, Asia and Rest of World. The Company's products include Crystaderm, Maxigesic, Coco-scalp, Maxiclear, RestoraNail and Myconail, among others. The Company's NasoSURF Nebuliser is in pilot scale production. The Company is focused on conducting clinical for Maxigesic oral dose forms. The Company is also conducting clinical trials of Maxigesic intravenous (IV). Maxigesic PE is a cold and flu variant. Its subsidiary, AFT Pharmaceuticals (AU) Pty Ltd, is engaged in distribution of pharmaceuticals in Australia. Its subsidiary, AFT Pharmaceuticals Singapore Pte Ltd, is engaged in the registration of pharmaceuticals in Singapore. Its subsidiary, AFT Pharmaceuticals (S.E. Asia) Sdn Bhd, is engaged in the distribution of pharmaceuticals in Malaysia.
Sales per Business
20192020
NZD
(in Million)
%NZD
(in Million)
%
Pharmaceutical 83.6598.3% 101.4296%
Licensing 1.221.4% 3.833.6%
Royalties 0.2550.3% 0.3560.3%
Sales per region
20192020
NZD
(in Million)
%NZD
(in Million)
%
Australia 50.3059.1% 61.4358.2%
New Zealand 26.8031.5% 30.1128.5%
Rest of World 5.896.9% 9.138.6%
Southeast Asia 2.142.5% 4.934.7%
Managers
Name Title
Hartley Atkinson Chief Executive Officer, MD & Executive Director
Malcolm Tubby Chief Financial Officer & Secretary
David Mark Flacks Chairman
Douglas John Wilson Independent Non-Executive Director
Jon Lamb Independent Non-Executive Director
James S. Burns Independent Non-Executive Director
Anita Baldauf Independent Non-Executive Director
Marree Atkinson Executive Director & Chief of Staff
Theodore J. Witek Director
Murray Keith Marketing Manager
Shareholders
Name Equities %
Norges Bank Investment Management 2,208,153 2.11%
Hartley Atkinson 1,617,818 1.55%
Accident Compensation Corp. 852,002 0.81%
Guardians of New Zealand Superannuation 737,134 0.70%
Jon Lamb 248,094 0.24%
Joeri Yvonne Jozef Sels 220,642 0.21%
Hamish Atkinson 190,000 0.18%
David Mark Flacks 178,764 0.17%
Joseph Wallace Carson 150,000 0.14%
James S. Burns 125,417 0.12%
Company contact information
AFT Pharmaceuticals Ltd.
Nielsen House
129 Hurstmere Road, Takapuna
Level 1
Auckland 0622

Phone : +64.800.423.823
Fax : +64.800.423.874
Web : http://www.aftpharm.com
Sector Other Pharmaceuticals
1st jan.Capi. (M$)
AFT PHARMACEUTICALS LIMITED-25.59%306
JOHNSON & JOHNSON3.09%427 130
ROCHE HOLDING AG0.16%289 376
PFIZER INC.2.15%215 150
NOVARTIS AG-3.73%198 528
MERCK & CO., INC.-5.29%196 100
ABBVIE INC.0.71%190 442
ELI LILLY AND COMPANY12.09%172 027
NOVO NORDISK A/S4.65%166 925
AMGEN INC.10.96%147 238
BRISTOL-MYERS SQUIBB COMPANY3.89%146 233
ASTRAZENECA PLC0.76%133 897
SANOFI8.02%127 185
GLAXOSMITHKLINE PLC0.33%92 715
JIANGSU HENGRUI MEDICINE CO., LTD.-27.67%65 639
CHUGAI PHARMACEUTICAL CO., LTD.-21.50%65 254
ALLERGAN PLC0.97%63 659
BAYER AG12.14%63 549
TAKEDA PHARMACEUTICAL COMPANY LIMITED-1.36%53 250
DAIICHI SANKYO COMPANY, LIMITED-14.99%52 906
ASTELLAS PHARMA INC.3.39%28 128